Transforming Growth Factor beta
Showing 1 - 25 of >10,000
0.25% Lemongrass Oil Mouthwash on Chronic Periodontitis
Completed
- Chronic Periodontitis
- 0.25% lemon grass oil mouthwash
-
Lahore, Punjab, PakistanPunjab dental hospital
Aug 15, 2022
Chitinases and Transforming Growth Factor Beta in Human Asthma
Completed
- Asthma
-
San Francisco, CaliforniaUCSF Airway Clinical Research Center
Jan 29, 2022
Pediatric Brain Tumor, Recurrent Pediatric Brain Tumor, Pediatric Supratentorial Tumor Trial in San Francisco (Universal Donor
Not yet recruiting
- Pediatric Brain Tumor
- +2 more
- Universal Donor (UD) Transforming growth factor beta imprinting (TGFβi) Natural Killer (NK) Cells
- Implantation
-
San Francisco, CaliforniaUniversity of California, San Francisco
May 24, 2023
Stage IA Non-Small Cell Lung Carcinoma, Stage IB Non-Small Cell Lung Carcinoma Trial in Palo Alto (biological, other, radiation)
Completed
- Stage IA Non-Small Cell Lung Carcinoma
- Stage IB Non-Small Cell Lung Carcinoma
- Fresolimumab
- +2 more
-
Palo Alto, CaliforniaStanford University, School of Medicine
Feb 2, 2022
Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in Houston
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +2 more
- Anti-TGF-beta Monoclonal Antibody SAR-439459
- Cemiplimab
-
Houston, TexasM D Anderson Cancer Center
Feb 9, 2022
Colorectal Cancer, Hematologic Malignancy, Rectum Cancer Trial in Cleveland (Vactosertib, Fludarabine Phosphate,
Recruiting
- Colorectal Cancer
- +11 more
- Vactosertib
- +4 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 18, 2023
Transitional Cell Carcinoma of Bladder Trial in Milan (PF03446962)
Completed
- Transitional Cell Carcinoma of Bladder
-
Milan, ItalyFondazione IRCCS Istituto Nazionale dei Tumori
May 12, 2021
Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Metastatic Trial in Boston (FOLFIRNINOX, Losartan, 9-ING-41)
Recruiting
- Pancreatic Adenocarcinoma
- Pancreatic Adenocarcinoma Metastatic
- FOLFIRNINOX
- +2 more
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Jun 7, 2022
Sepsis, Severe Trial (probiotics( Lactobacillus acidophilus, lactobacillus delbruekii and lactobacillus fermentum 10 billions),,
Not yet recruiting
- Sepsis, Severe
- probiotics( Lactobacillus acidophilus, lactobacillus delbruekii and lactobacillus fermentum 10 billions),
- maltose dissolved in distilled water
- (no location specified)
Jul 18, 2022
Renal Cell Carcinoma Trial in Little Brunswick (Anti-Transforming Growth Factor-beta (GC 1008))
Completed
- Renal Cell Carcinoma
- Anti-Transforming Growth Factor-beta (GC 1008)
-
Little Brunswick, New JerseyCancer Institute of New Jersey
Oct 26, 2019
TGF-(Beta) and Susceptibility to RSV
Completed
- Asthma
-
Research Triangle Park, North CarolinaNIEHS Clinical Research Unit (CRU)
Jan 7, 2023
Colorectal Cancer Trial in Oslo (Adoptive Cell Therapy (ACT))
Terminated
- Colorectal Cancer
- Adoptive Cell Therapy (ACT)
-
Oslo, NorwayOslo University Hospital
Jun 12, 2019
Menopause Trial (YesMilkdiet, NoMilkdiet)
Not yet recruiting
- Menopause
- YesMilkdiet
- NoMilkdiet
- (no location specified)
Sep 16, 2023
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte (procedure, biological, drug,
Recruiting
- Acute Lymphoblastic Leukemia
- +3 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 12, 2023
Ischemic Cardiomyopathy, Diabetes Trial in Damanhur (Alpha Lipoic Acid 600 MG Oral Tablet, Placebo Tablet)
Recruiting
- Ischemic Cardiomyopathy
- Diabetes Mellitus
- Alpha Lipoic Acid 600 MG Oral Tablet
- Placebo Tablet
-
Damanhūr, Elbehairah, EgyptDamanhour Teaching Hospital, General Organization for Teaching H
Sep 26, 2023
Hereditary Hemorrhagic Telangiectasia Trial in Essen (hypoxic induced factors)
Recruiting
- Hereditary Hemorrhagic Telangiectasia
- hypoxic induced factors
-
Essen, NRW, GermanyUniversity Hospital Essen
Mar 21, 2022
HER2-positive Breast Cancer, Operable Breast Cancer Trial in France (Trastuzumab + Paclitaxel, Pegfilgrastim)
Recruiting
- HER2-positive Breast Cancer
- Operable Breast Cancer
- Trastuzumab + Paclitaxel
- Pegfilgrastim
-
Avignon, France
- +8 more
Jan 9, 2023
Multiple Myeloma Trial (BCMA-TGFß CAR-T cells (0.75 x10^6 cells/kg), BCMA-TGFß CAR-T cells (1 x 10^6 cells/kg), BCMA-TGFß CAR-T
Not yet recruiting
- Multiple Myeloma
- BCMA-TGFβ CAR-T cells (0.75 x10^6 cells/kg)
- +3 more
- (no location specified)
Jul 28, 2023
Arrhythmogenic Right Ventricular Dysplasia Trial in Toulouse (Peripheral immunological assessment on venous blood, Immunological
Recruiting
- Arrhythmogenic Right Ventricular Dysplasia
- Peripheral immunological assessment on venous blood
- Immunological assessment carried out on intracardiac material
-
Toulouse, FranceToulouse University Hospital Center
Aug 17, 2022
Non Alcoholic Steatohepatitis Trial in Tanta (Pioglitazone 30mg, Empagliflozin 10 MG)
Not yet recruiting
- Non Alcoholic Steatohepatitis
- Pioglitazone 30mg
- Empagliflozin 10 MG
-
Tanta, Gharbiya, EgyptTanta University
Nov 2, 2022
Tendinopathy Trial in Taoyuan (Platlet-rich plasma)
Recruiting
- Tendinopathy
- Platlet-rich plasma
-
Taoyuan, TaiwanTaoyuan Chang Gung Memorial Hospital
Mar 14, 2022
Periodontal Pocket Trial in Baghdad (Lycopene, Minocycline HCl 1mg Oral Powder, Distilled water)
Unknown status
- Periodontal Pocket
- Lycopene
- +2 more
-
Baghdad, IraqCollege of Dentistry/ University of Baghdad
May 23, 2019
Pre-diabetes Trial in Québec (Low fat diet, High fat diet)
Recruiting
- Pre-diabetes
- Low fat diet
- High fat diet
-
Québec, Quebec, CanadaInstitute of Nutrition and Functional Foods (INAF)
Jul 20, 2023